SLC29A1 抗体
SLC29A1 适用: 人, 小鼠 WB, IHC (p), FACS 宿主: 兔 Polyclonal RB09157 unconjugated
SLC29A1 适用: 人 WB, ELISA, IHC, IF 宿主: 兔 Polyclonal unconjugated
SLC29A1 抗体 by Grade
Find SLC29A1 抗体 with a specific Grade. The Grade listed below are among those available. Click on a link to go to the corresponding products.
SLC29A1 抗体 by 抗体来源
Find SLC29A1 抗体 with a specific 抗体来源. The 抗体来源 listed below are among those available. Click on a link to go to the corresponding products.
SLC29A1 抗体 by 克隆形成能力
Find available monoclonal or polyclonal SLC29A1 抗体. Click on a link to go to the corresponding products.
SLC29A1 抗体 by 克隆
Find SLC29A1 抗体 with a specific 克隆. The 克隆 listed below are among those available. Click on a link to go to the corresponding products.
Popular SLC29A1 抗体
- (3)
- (5)
- (3)
- (2)
- (2)
- (2)
- (2)
- (2)
- (2)
- (2)
- (1)
- (2)
- (1)
- (1)
- (1)
- (1)
- (1)
- (1)
Latest Publications for our SLC29A1 抗体
: "Apoptotic brown adipocytes enhance energy expenditure via extracellular inosine." in: Nature, (2022) (PubMed).: "In Vitro and In Vivo Comparison of Gemcitabine and the Gemcitabine Analog 1-(2'-deoxy-2'-fluoroarabinofuranosyl) Cytosine (FAC) in Human Orthotopic and Genetically Modified Mouse Pancreatic Cancer ..." in: Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging, (2017) (PubMed).
: "Establishment and characterization of hypomethylating agent-resistant cell lines, MOLM/AZA-1 and MOLM/DEC-5." in: Oncotarget, Vol. 8, Issue 7, pp. 11748-11762, (2017) (PubMed).
: "Concurrent analysis of human equilibrative nucleoside transporter 1 and ribonucleotide reductase subunit 1 expression increases predictive value for prognosis in cholangiocarcinoma patients treated ..." in: British journal of cancer, Vol. 111, Issue 7, pp. 1275-84, (2014) (PubMed).
: "Combined analysis of intratumoral human equilibrative nucleoside transporter 1 (hENT1) and ribonucleotide reductase regulatory subunit M1 (RRM1) expression is a powerful predictor of survival in ..." in: Surgery, Vol. 153, Issue 4, pp. 565-75, (2013) (PubMed).
: "Combined analysis of dihydropyrimidine dehydrogenase and human equilibrative nucleoside transporter 1 expression predicts survival of pancreatic carcinoma patients treated with adjuvant gemcitabine ..." in: Annals of surgical oncology, Vol. 19 Suppl 3, pp. S646-55, (2012) (PubMed).
: "Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice. ..." in: The Journal of clinical investigation, Vol. 122, Issue 2, pp. 693-710, (2012) (PubMed).
: "Host-based ribavirin resistance influences hepatitis C virus replication and treatment response." in: Journal of virology, Vol. 85, Issue 14, pp. 7273-83, (2011) (PubMed).
: "Enhanced efficacy of gemcitabine by indole-3-carbinol in pancreatic cell lines: the role of human equilibrative nucleoside transporter 1." in: Anticancer research, Vol. 31, Issue 10, pp. 3171-80, (2011) (PubMed).
: "Reduced ribavirin antiviral efficacy via nucleoside transporter-mediated drug resistance." in: Journal of virology, Vol. 83, Issue 9, pp. 4538-47, (2009) (PubMed).
Aliases for SLC29A1 抗体
solute carrier family 29 member 1 (Augustine blood group) (SLC29A1) 抗体solute carrier family 29 member 1 (Slc29a1) 抗体
solute carrier family 29 (nucleoside transporters), member 1 (Slc29a1) 抗体
1200014D21Rik 抗体
AA407560 抗体
ENT1 抗体
rENT1 抗体
